M1 Kliniken AG (ETR:M12)

M1 Kliniken AG Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	20.23	22.13	16.02	10.27	4.32	8.91
Depreciation & Amortization	4.41	4.88	5.16	5.31	5.86	5.64
Loss (Gain) From Sale of Assets	0.99	0.99	0.01	-0.04	0.13	0.06
Other Operating Activities	-2.65	3.09	7.5	1.11	3.1	4.72
Change in Accounts Receivable	1.04	2.84	13.64	7.29	-4.38	-15.54
Change in Inventory	1.84	11.77	8.72	-17.18	7.6	7.13
Change in Accounts Payable	2.9	-7.95	-20.2	1.02	4.97	5.25
Change in Other Net Operating Assets	-1.44	0.19	-0.3	0.02	-0.82	-0.48
Operating Cash Flow	27.32	37.95	30.55	7.81	20.77	15.68
Operating Cash Flow Growth	-22.16%	24.23%	291.14%	-62.40%	32.41%	64.40%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-0.21	-0.11	-0.77	-0.45	-1.16	-1.03
Sale of Property, Plant & Equipment	0.03	0.06	0.01	0.05	0.07	0.18
Divestitures	-	-	-	-	-	1.08
Sale (Purchase) of Intangibles	0.17	0.12	-	-0.55	-0.61	-0.31
Investment in Securities	23.46	0.32	-4.91	-9.1	-0.07	-
Other Investing Activities	-4.37	-3.99	-	0.69	0.65	0.29
Investing Cash Flow	19.08	-3.59	-5.67	-9.36	-1.12	0.21

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Repaid	-	-4.1	-18.58	-28.9	-4.59	-8.29
Lease Payments	-3.76	-4.1	-4.14	-4.16	-4.59	-4.08
Net Debt Issued (Repaid)	-3.76	-4.1	-18.58	-28.9	-4.59	-8.29
Issuance of Common Stock	-	-	0.85	7.58	-	2.01
Repurchase of Common Stock	-0	-0	-1.88	-3.63	-15.55	-
Common Dividends Paid	-9.31	-9.31	-9.31	-1.98	-1.82	-1.66
Other Financing Activities	-0.7	-1.2	-1.53	-0.89	-0.4	11.97
Financing Cash Flow	-13.76	-14.61	-30.44	-27.82	-22.37	4.03

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	0.33	0.06	-0.1	0.07	-0.01	-0.01
Miscellaneous Cash Flow Adjustments	-5.91	2.39	-0	13.01	-0	-
Net Cash Flow	27.06	22.19	-5.66	-16.29	-2.72	19.91

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	27.1	37.84	29.78	7.35	19.61	14.66
Free Cash Flow Growth	-21.02%	27.07%	304.89%	-62.49%	33.76%	69.77%
Free Cash Flow Margin	10.47%	10.39%	8.78%	2.33%	6.87%	4.66%
Free Cash Flow Per Share	1.45	2.04	1.60	0.39	1.07	0.79
Levered Free Cash Flow	25.84	36.31	23.49	5.08	16.91	30.98
Unlevered Free Cash Flow	26.44	37.28	24.69	5.92	17.43	31.55
Free Cash Flow After Leases	23.35	33.74	25.64	3.2	15.01	10.58

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	1.2	1.2	1.53	0.89	0.4	0.51
Cash Income Tax Paid	9.28	9.28	5.91	4.38	2.16	0.03
Change in Working Capital	4.33	6.85	1.86	-8.85	7.37	-3.64

Data Source: S&P Global Market Intelligence Last updated: May 20, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 16, 2026

Data Sources Report a data error